Drug Shortage Report for OXY.IR
Report ID | 242888 |
Drug Identification Number | 02231934 |
Brand name | OXY.IR |
Common or Proper name | Oxycodone Hydrochloride Immediate Release Tablets |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | OXYCODONE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-11-13 |
Actual start date | 2024-11-13 |
Estimated end date | 2024-11-29 |
Actual end date | 2024-11-25 |
Shortage status | Resolved |
Updated date | 2024-11-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-11-26 | English | Compare |
v7 | 2024-11-25 | French | Compare |
v6 | 2024-11-25 | English | Compare |
v5 | 2024-11-21 | French | Compare |
v4 | 2024-11-21 | English | Compare |
v3 | 2024-11-14 | English | Compare |
v2 | 2024-11-13 | French | Compare |
v1 | 2024-11-13 | English | Compare |
Showing 1 to 8 of 8